As of 2025-09-17, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (34.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.64 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -307.5%.
The range of the Relative Valuation is (31.06) - (35.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.5x - 41.6x | 36.6x |
| Forward P/E multiples | 30.7x - 34.8x | 31.7x |
| Fair Price | (31.06) - (35.23) | (34.53) |
| Upside | -286.7% - -311.7% | -307.5% |
| Date | P/E |
| 2025-09-11 | -14.93 |
| 2025-09-10 | -14.61 |
| 2025-09-09 | -14.78 |
| 2025-09-08 | -14.87 |
| 2025-09-05 | -14.94 |
| 2025-09-04 | -15.00 |
| 2025-09-03 | -14.83 |
| 2025-09-02 | -14.94 |
| 2025-08-29 | -15.37 |
| 2025-08-28 | -15.39 |
| 2025-08-27 | -15.68 |
| 2025-08-26 | -16.72 |
| 2025-08-25 | -16.31 |
| 2025-08-22 | -16.86 |
| 2025-08-21 | -15.82 |
| 2025-08-20 | -15.77 |
| 2025-08-19 | -15.69 |
| 2025-08-18 | -15.51 |
| 2025-08-15 | -15.98 |
| 2025-08-14 | -17.12 |
| 2025-08-13 | -16.61 |
| 2025-08-12 | -14.93 |
| 2025-08-11 | -14.72 |
| 2025-08-08 | -14.55 |
| 2025-08-07 | -14.56 |
| 2025-08-06 | -15.17 |
| 2025-08-05 | -15.08 |
| 2025-08-04 | -14.90 |
| 2025-08-01 | -14.59 |
| 2025-07-31 | -14.85 |
| 2025-07-30 | -14.57 |
| 2025-07-29 | -14.55 |
| 2025-07-28 | -15.04 |
| 2025-07-25 | -14.77 |
| 2025-07-24 | -14.71 |
| 2025-07-23 | -15.00 |
| 2025-07-22 | -14.99 |
| 2025-07-21 | -14.81 |
| 2025-07-18 | -14.93 |
| 2025-07-17 | -15.48 |
| 2025-07-16 | -15.55 |
| 2025-07-15 | -15.05 |
| 2025-07-14 | -15.89 |
| 2025-07-11 | -15.85 |
| 2025-07-10 | -16.93 |
| 2025-07-09 | -16.01 |
| 2025-07-08 | -15.36 |
| 2025-07-07 | -15.64 |
| 2025-07-03 | -15.13 |
| 2025-07-02 | -15.15 |